Growth Financing through Class Shares, Bonds with Stock Acquisition Rights, and Stock Acquisition Rights
First written in FY2023-Q2. 1 of 3 entries say "Achieved", first in FY2023-Q3. Latest entry: FY2023.
No other company in this theme has enough history to compare yet.
- FY2023Change in use of proceeds disclosedAnnual report
「Regarding this capital participation, we changed the use of proceeds because we decided to allocate part of the funds raised through the convertible bonds with stock acquisition rights for which payment was completed on 31 January 2023.」
After completing the third-party allotment financing, we changed the use of proceeds and planned to allocate ¥1,491 million raised through the convertible bonds with stock acquisition rights to M&A and other purposes. - FY2023-Q3AchievedAnnual report
「On 31 January 2023, we issued Class A preferred shares to AAGS S3 as the allottee and received payment of ¥1,999,952 thousand on the same date. We also issued the 2nd Series Stock Acquisition Rights to AAGS S3, with 23 January 2023 as the allotment date, and received payment of ¥11,673 thousand on 31 January 2023. We issued the 1st Series unsecured convertible bonds with stock acquisition rights to AAGS S3, with 23 January 2023 as the allotment date, and received payment of ¥1,499,988 thousand on 31 January 2023.」
The issuance and payment for the Class A preferred shares, stock acquisition rights, and bonds with stock acquisition rights through a third-party allotment were completed, and we received total payment of approximately ¥3.51161 billion. - FY2023-Q2First statedAnnual report
「The specific intended uses of the estimated net proceeds of ¥4,985,778,360 are as follows: (a) New store openings in Japan based on an optimal store mix: ¥1,991 million, January 2023 to January 2026; (b) New Genki Gym openings and development of new preventive-care facilities in the healthcare business: ¥1,300 million, January 2023 to January 2026; (c) Costs for introducing DX tools and related expenses: ¥191 million, January 2023 to January 2026; and (d) Business expansion through M&A and other means: ¥1,503 million, January 2023 to January 2026.」
We presented a plan to raise estimated net proceeds of approximately ¥4.986 billion through a third-party allotment of Class A preferred shares, bonds with stock acquisition rights, and stock acquisition rights. The proceeds were planned for use in domestic store openings, development of healthcare facilities including Genki Gym, DX, and M&A from January 2023 through January 2026.